take off after the AGM, page-16

First 16 Last

Share
Profile

Follow
s1r1us

1,301 Posts.

551

14/11/19

08:47

Post #: 41414503
Share
Originally posted by NavyDiver ↑

I'll be at the meeting this afternoon. Looking forward to it after being very tempted to go to Perth over the last few years. Was in the City two days ago and have scoped out where to park and where it is already.

Mine include if not already answered before I ask.

Market Potential/expectation for use in each market starting here in Oz for Ovarian, Lung and Breast cancer tests I specifically want to know % of our population which will benefit from the test(s)

Repeat market Potential/expectation ( cervical screening for example was every few years as are Mammograms)

Has the Move to the East Coast delivered to the goals set out in Growth Strategy announced 31 July 2109

Time frame for LDT Ovarian and Lung and Breast cancer tests ( full expect not to ask this one as it will be given

Promotion of the Ovarian, Lung and Breast cancer tests here and OS costs and time frame

Third party involvement. we all know about Thermo Fisher- does/has this put constraints on announcements at all

For Q1 I want to know if the LDT is consumer driven, General Practitioners or only specialists, Q2 is really a key. I do not think BD1 tests are one of one hit wonders and will form a part of long term health care regular blood test similar to cholesterol and blood pressure checks we do by the millions every year.

What questions would you like. No such thing as a dumb question Have a great day. I will as I am looking forward to meeting our very cool team

Expand

Many thanks ND...will be great to hear the answers.
Cheers.
BD1 Price at posting: 4.3¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

TON

Triton snaffles 588 square km gold-copper play in Mozambique

ATC

Altech launches CERENERGY prototype in Germany, with early tests proving positive

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BM8

Battery Age Minerals launches field campaign at Austrian Bleiberg lead-zinc-germanium play

There are more pages in this discussion • 122 more messages in this thread...

First 16 Last

Add IIQ (ASX) to my watchlist

(20min delay)
Last 48.0¢		Change -0.020(4.00%)		Mkt cap ! $53.53M

Open	High	Low	Value	Volume
48.0¢	50.0¢	47.5¢	$51.48K	105.9K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	48.0¢

Sellers (Offers)

Price($)	Vol.	No.
48.5¢	10000	2

View Market Depth

No.	Vol.	Price($)
1	1900	0.480
3	41187	0.475
2	26170	0.470
3	23650	0.465
4	46410	0.460

Price($)	Vol.	No.
0.485	10000	2
0.495	1500	1
0.500	7362	1
0.505	28000	3
0.510	20000	2

Last trade - 11.49am 01/10/2024 (20 minute delay)

IIQ (ASX) Chart

take off after the AGM, page-16

Triton snaffles 588 square km gold-copper play in Mozambique

Altech launches CERENERGY prototype in Germany, with early tests proving positive

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Battery Age Minerals launches field campaign at Austrian Bleiberg lead-zinc-germanium play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

take off after the AGM, page-16

Top Stories

Triton snaffles 588 square km gold-copper play in Mozambique

Altech launches CERENERGY prototype in Germany, with early tests proving positive

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Battery Age Minerals launches field campaign at Austrian Bleiberg lead-zinc-germanium play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News